Impact of improved price transparency on patients' demand of healthcare services

Daiki Kobayashi, Rei Goto, Yusuke Tsugawa

Research output: Contribution to journalArticle

Abstract

Evidence is limited and mixed as to how improved price transparency affects patients' demand for healthcare. Price transparency usually affects both the supply and the demand side of healthcare. However, in Japan—where healthcare providers cannot compete on prices—we can examine an independent impact of price transparency on patients' demand for healthcare. The aim of this study is to investigate the impact of improved price transparency on patients' demand for healthcare. We conducted an experiment by presenting patients with the “price list” of individual healthcare services. We provided the price list for a limited time and compared the healthcare spending and utilization of care between these patients who were provided the price list (patients who visited between the first and third week of January in 2016) versus those who were not (patients who visited during the same period in 2015 or 2017), adjusting for potential confounders. A total of 1053 patients were analyzed (27.5% were provided the price list). We found that improved price transparency was associated with a higher total cost per patient (adjusted difference, +16.1%; 95%CI, +0.6% to +34.0%; p = 0.04). We also found that improved price transparency was associated with higher costs related to laboratory tests and imaging studies, and a larger total number of items of blood tests and urine tests. By conducting an experiment in a real-world setting, we found that improved price transparency paradoxically increased the utilization of healthcare services in Japan. These findings suggest that when prices are relatively low, as is the case in Japan, reduced uncertainty about the prices of healthcare service may make patients comfortable requesting more healthcare services.

Original languageEnglish
Article number112390
JournalSocial Science and Medicine
Volume235
DOIs
Publication statusPublished - 2019 Aug 1

Fingerprint

transparency
Delivery of Health Care
demand
Healthcare
Transparency
Japan
utilization
Costs and Cost Analysis
experiment
costs
Hematologic Tests
Health Personnel
Uncertainty
Patient Care
uncertainty
supply
Urine

Keywords

  • Costs of care
  • Demand of care
  • Patient behavior
  • Price transparency

ASJC Scopus subject areas

  • Health(social science)
  • History and Philosophy of Science

Cite this

Impact of improved price transparency on patients' demand of healthcare services. / Kobayashi, Daiki; Goto, Rei; Tsugawa, Yusuke.

In: Social Science and Medicine, Vol. 235, 112390, 01.08.2019.

Research output: Contribution to journalArticle

@article{2b32bb90a5d6451882299293ffdd1c19,
title = "Impact of improved price transparency on patients' demand of healthcare services",
abstract = "Evidence is limited and mixed as to how improved price transparency affects patients' demand for healthcare. Price transparency usually affects both the supply and the demand side of healthcare. However, in Japan—where healthcare providers cannot compete on prices—we can examine an independent impact of price transparency on patients' demand for healthcare. The aim of this study is to investigate the impact of improved price transparency on patients' demand for healthcare. We conducted an experiment by presenting patients with the “price list” of individual healthcare services. We provided the price list for a limited time and compared the healthcare spending and utilization of care between these patients who were provided the price list (patients who visited between the first and third week of January in 2016) versus those who were not (patients who visited during the same period in 2015 or 2017), adjusting for potential confounders. A total of 1053 patients were analyzed (27.5{\%} were provided the price list). We found that improved price transparency was associated with a higher total cost per patient (adjusted difference, +16.1{\%}; 95{\%}CI, +0.6{\%} to +34.0{\%}; p = 0.04). We also found that improved price transparency was associated with higher costs related to laboratory tests and imaging studies, and a larger total number of items of blood tests and urine tests. By conducting an experiment in a real-world setting, we found that improved price transparency paradoxically increased the utilization of healthcare services in Japan. These findings suggest that when prices are relatively low, as is the case in Japan, reduced uncertainty about the prices of healthcare service may make patients comfortable requesting more healthcare services.",
keywords = "Costs of care, Demand of care, Patient behavior, Price transparency",
author = "Daiki Kobayashi and Rei Goto and Yusuke Tsugawa",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.socscimed.2019.112390",
language = "English",
volume = "235",
journal = "Social Science and Medicine",
issn = "0277-9536",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Impact of improved price transparency on patients' demand of healthcare services

AU - Kobayashi, Daiki

AU - Goto, Rei

AU - Tsugawa, Yusuke

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Evidence is limited and mixed as to how improved price transparency affects patients' demand for healthcare. Price transparency usually affects both the supply and the demand side of healthcare. However, in Japan—where healthcare providers cannot compete on prices—we can examine an independent impact of price transparency on patients' demand for healthcare. The aim of this study is to investigate the impact of improved price transparency on patients' demand for healthcare. We conducted an experiment by presenting patients with the “price list” of individual healthcare services. We provided the price list for a limited time and compared the healthcare spending and utilization of care between these patients who were provided the price list (patients who visited between the first and third week of January in 2016) versus those who were not (patients who visited during the same period in 2015 or 2017), adjusting for potential confounders. A total of 1053 patients were analyzed (27.5% were provided the price list). We found that improved price transparency was associated with a higher total cost per patient (adjusted difference, +16.1%; 95%CI, +0.6% to +34.0%; p = 0.04). We also found that improved price transparency was associated with higher costs related to laboratory tests and imaging studies, and a larger total number of items of blood tests and urine tests. By conducting an experiment in a real-world setting, we found that improved price transparency paradoxically increased the utilization of healthcare services in Japan. These findings suggest that when prices are relatively low, as is the case in Japan, reduced uncertainty about the prices of healthcare service may make patients comfortable requesting more healthcare services.

AB - Evidence is limited and mixed as to how improved price transparency affects patients' demand for healthcare. Price transparency usually affects both the supply and the demand side of healthcare. However, in Japan—where healthcare providers cannot compete on prices—we can examine an independent impact of price transparency on patients' demand for healthcare. The aim of this study is to investigate the impact of improved price transparency on patients' demand for healthcare. We conducted an experiment by presenting patients with the “price list” of individual healthcare services. We provided the price list for a limited time and compared the healthcare spending and utilization of care between these patients who were provided the price list (patients who visited between the first and third week of January in 2016) versus those who were not (patients who visited during the same period in 2015 or 2017), adjusting for potential confounders. A total of 1053 patients were analyzed (27.5% were provided the price list). We found that improved price transparency was associated with a higher total cost per patient (adjusted difference, +16.1%; 95%CI, +0.6% to +34.0%; p = 0.04). We also found that improved price transparency was associated with higher costs related to laboratory tests and imaging studies, and a larger total number of items of blood tests and urine tests. By conducting an experiment in a real-world setting, we found that improved price transparency paradoxically increased the utilization of healthcare services in Japan. These findings suggest that when prices are relatively low, as is the case in Japan, reduced uncertainty about the prices of healthcare service may make patients comfortable requesting more healthcare services.

KW - Costs of care

KW - Demand of care

KW - Patient behavior

KW - Price transparency

UR - http://www.scopus.com/inward/record.url?scp=85068983511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068983511&partnerID=8YFLogxK

U2 - 10.1016/j.socscimed.2019.112390

DO - 10.1016/j.socscimed.2019.112390

M3 - Article

C2 - 31325901

AN - SCOPUS:85068983511

VL - 235

JO - Social Science and Medicine

JF - Social Science and Medicine

SN - 0277-9536

M1 - 112390

ER -